• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Integrity Applications inks exclusive Dutch distro deal for GlucoTrack

December 28, 2017 By Fink Densford

Integrity Applications

Integrity Applications said today it inked an exclusive distribution deal with MediReva B.V. to distribute its GlucoTrack non-invasive glucose measuring device in the Netherlands, effective December 22.

Integrity Application’s flagship GlucoTrack is a sensor that clips to the earlobe and uses a combination of metrics to determine blood glucose based on physiological changes in the body.

“This distribution agreement in the Netherlands is a major milestone on our path to commercializing GlucoTrack. It represents an important first program in our updated commercial partnering strategy. We are excited to work with MediReva to launch GlucoTrack in the Netherlands, and we look forward to continuing our efforts in making the device available for patients in markets around the world,” chief commercial officer David Podwalski said in a press release.

MediReva is a family owned business that covers the entirety of the Netherlands alongside limited coverage in Belgium and Luxembourg, according to Wilmington, Del.-based Integrity Applications.

As part of the agreement, MediReva will commit substantial resources including dedicated sales and customer support staff for the GlucoTrack, Integrity Applications said.

“MediReva is one of the leading home care support companies in the Netherlands. We have years of experience in helping patients manage their diabetes and we are excited about bringing GlucoTrack to the marketplace,” MediReva CEO Paul Ummels said in a prepared statement.

Filed Under: Business/Financial News, Diabetes, Featured Tagged With: integrityapplications

IN CASE YOU MISSED IT

  • Tandem Diabetes Care delivers 1 million insulin boluses using t:connect mobile app
  • Nuvo, Sheba Medical Center develop AI-powered gestational diabetes management platform
  • Verily’s Onduo, Sword Health collaborate on virtual diabetes care
  • Shareholder lawsuit over BD’s Alaris pumps recall moves forward
  • Embecta stock soars on first full-quarter results after BD spinoff

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS